CUBT Financials
Curative Biotechnology Inc - Financial statements & key metrics
Stock Price
$0.99
Market Cap
$7.15M
EPS
$-0.70
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
-
Gross Profit
$-87843.00
Operating Income
$-1.50M
Net Income
$-2.26M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$2.11M
Total Liabilities
$8.20M
Shareholders Equity
$-6.09M
Cash & Equivalents
$45043.00
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-868866.00
CapEx
$4
Free Cash Flow
$-868,870
Profitability Metrics
Gross Margin
75.7%
ROE
-4.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CUBT revenue?
View CUBT's income statement for detailed revenue data.
Is CUBT profitable?
CUBT reported a loss of $2.26M in the most recent quarter.
What is CUBT market cap?
CUBT has a market capitalization of $7.15M, making it a small-cap stock.
Does CUBT have debt?
View CUBT's balance sheet for debt information.
What is CUBT cash flow?
CUBT's most recent quarterly free cash flow was $-868,870.